BIMOVIS’ Post

🌟 Day 1 Highlights from BIOVIA Live Europe 2024! 🌟 BIOVIA LIVE kicked off with a vibrant start, diving into innovative sessions and hands-on workshops. Key topics included AI in research, lab productivity, and sustainable materials innovation. Attendees engaged in dynamic discussions and networking opportunities, setting the stage for groundbreaking collaborations. Exciting times ahead as we continue to explore cutting-edge scientific advancements! Who wants to learn more about working in a more data-centric way in science? Let’s connect and have a chat about how we at TECHNIA can support YOU to drive your innovations! Who has the first question? #BIOVIALiveEurope2024 #Innovation #ScientificResearch #TECHNIA #BIOVIA #DassaultSystèmes #Sustainability

🤔 What are the new frontiers in #TechBio? How do we see the intersection of biology and tech evolving?   This Wednesday was the launch of a new HTBC TechBio chapter led by Leigh Brody, AlbionVC life sciences investor. TechBio Club is a breakfast session that welcomes founders, operators, and investors for a quarterly deepdive on the state of the TechBio ecosystem.   Thank you to our stellar first panel: Javier Nunez-Vicandi, Sofinnova Partners, Paul Ashley, Johnson & Johnson, Ian McKay, Innovate UK Leigh Brody, AlbionVC (Moderator) Key take-aways from the discussion include: 🖖 There remains a gap in the investment landscape - techbio companies require investors with understanding both tech and bio 👨💻 The growth of techbio has been in part thanks to AI within the life science sector, but challenges around genetic data, regulatory hurdles, ethical considerations and incorporation into clinical practice are just a few of the hurdles 🌍 It's expected that there will be a streamlining of aids targeting 'low-hanging' problems soon, highlighting the dynamic nature of the field and the ongoing quest for innovation Many thanks to HSBC Innovation Banking for hosting this quarter's session at their offices and supporting this event. If you are operating in the space and would like to join the next session, register your interest here: https://lnkd.in/e_bW72gw #healthcare #techbio #digitalhealth #deeptech #lifesciences #ai #drugdiscovery #vc #founders #operators #experts #investors #venturecapital #community

Are you attending BIO 2024 in San Diego next week (3-6 June 2024)? Then visit our CEO and founder, Nikola Müller, at booth 4315 in the German Pavilion. knowing01 GmbH is a Munich-based start-up founded in 2020 with the mission to change the way life science data is used in research. Our goal is to help researchers in industry and academia get more out of their data, accelerate discoveries and create impact. Our easy-to-use software deeply connects biomedical datasets for robust insights and separates signal from noise. Would you like to learn more about knowing01's flexible software solution? Or how you can effectively contextualize Multiomics data for in silico testing and target identification? Then now is your chance to meet our CEO and founder, Dr Nikola Müller, at booth 4315 (German Pavilion) at BIO International Convention 2024 in San Diego from 3-6 June 2024. You can make a meeting request with KNOWING01 in the BIO partnering system: https://lnkd.in/ddSxCXMH Or contact us at: https://lnkd.in/edhAhvpZ #BIO2024 #GermanPavilion #knowing01 #StartUp #Biotechnology #Multiomics #Omics #DiseaseResearch #DataScience #DataAnalytics #AI #KnowledgeGraphs #Innovation #Research #WomenInIT #FemaleLeaders

Last night I had the pleasure of being the first of 4 invited speakers for the BioMelbourne Network BioForum - AI-Driven Drug Discovery: Accelerating Innovation. Thanks for allowing me to share my thoughts on where AI is working well in drug discovery and where improvements still need to be made. #machinelearning #drugdiscovery

💡 UbiquiTx, Inc. wins $275,000 award from National Science Foundation, National Science Foundation! This award is part of the Small Business Innovation Research (SBIR) Phase I program. The project aims to develop a programmable modular therapeutic platform for the direct modification of proteins of interest via artificial intelligence protein engineering and mRNA as a therapeutic entity. This technology has the potential to advance the health and welfare of the American public and enhance partnerships between academia and industry. #SBIR #STTR #Healthcare 🔬 The project will focus on leveraging engineered enzymes to recognize and edit proteins of interest by removing/installing post-translational modifications rapidly and precisely. The goal is to expand the applications of the platform by designing and implementing new protein editors. 📆 This award is part of the Small Business Innovation Research (SBIR) Phase I program and will last for 12 months, starting from July 15, 2024, and ending on June 30, 2025.

Join the BioFense Hackathon 2024! 🚀 We're thrilled to announce the BioFense Hackathon, a groundbreaking, month-long bio-convergence hackathon designed to tackle real industry challenges. Powered by Nucleate Israel and sponsored by the top industry leaders Teva Pharmaceuticals and DDR&D (MAFAT) - Directorate of Defense Research & Development , this is your chance to innovate and make a significant impact! ⌛ About BioFense Hackathon: • Dates: June 2nd-26th • Duration: One month of intense innovation- • F2F Kick-off event – June 2nd! • Zoom workshops & Working with the mentors – June 3rd-24th! • F2F Closing competitions – June 25th-26th! 🪙Tracks: • Biomedical Track: Partnered with The Medical Corps • Eco Track: Partnered with E44 Ventures & FRESH START FoodTech Incubator IL • Resilience Track: Sponsored by DDR&D (MAFAT) - Directorate of Defense Research & Development & Partnered with Rafael & Elbit Systems Israel • Mental Health Track: Sponsored by Teva Pharmaceuticals & Partnered with DDR&D (MAFAT) - Directorate of Defense Research & Development 💡 Why Participate?: • Mentorship: Each team will be guided by a leading technical mentor, a business mentor, and a Nucleate mentor to help you develop your product. • Networking: Connect with industry experts, fellow innovators, and potential investors. • Exposure: Present your pitch deck to an esteemed panel of judges at the final competition. • Help restore the ecosystem: your ideas might be what everyone is looking for, solve real industry challenges and create solutions with real impact and market need. 🎯 Target Audience: • Students, Innovators, entrepreneurs, scientists, engineers, and anyone passionate about bio-convergence and technology. Whether you're an individual or a team of up to 4, we want you! 📅 Important Dates: • Registration Deadline: May 23rd • Hackathon Start: June 2nd 🚀 Ready to innovate? Register now! https://lnkd.in/gsE5HYnB Don't miss this opportunity to be part of something transformative. Let's create solutions that make a difference. Share this post and invite your friends to join! #hackathon #biofense #nucleate #bioconvergence #technology #ecosystem #innovative #israel

🧬🎯 Unlock the power of precision mutant libraries with Cedric Wu and Xing Gao from GenScript, Possu Huang from Stanford, and Audrey Robic from Allozymes in "Accelerating Revolution in Biotech and BioPharma: The Power of Precision Mutant Libraries" at #synbiobeta2024!

2035: Will the "valley of death" in biotech funding be ancient history? Community-led biotech & radical experimentation back in the hands of the people. Crowdsourced tokenized research, decentralized labs, and open-source biology platforms democratize innovation. Citizen scientists, researchers, and passionate hobbyists drive breakthroughs, challenging corporate giants and accelerating scientific progress. A new era of biohacking and ethical bio-design emerges, blurring the lines between medicine & technology. As regulations adapt to this paradigm shift, a vibrant ecosystem of bio-cooperatives and community-owned biobanks thrives. Healthcare becomes more accessible, personalized, and affordable. The future of medicine is rewritten, one experiment at a time. = bio/acc

We're thrilled to reveal the 11 companies participating in the first Founders at the University of Cambridge Start accelerator 🎙 I moved to Cambridge to work with amazing people, and this group of technologists and scientists trying to solve many of the world's big issues has blown me away. As someone who doesn't have a science background, I'm having so much fun being the dumbest guy in the room. I can't wait to see where they get to over the next three months of our programme - and beyond. Check out this amazing list. 🫧AetoSense, led by Molly Haugen, is building low-cost and high-accuracy indoor air quality monitoring sensors 🦠 BioTryp Therapeutics, led by Ashraf Zarkan, is dividing bacteria to end overreliance on traditional antibiotics 🧪 BravelyCultured, led by Natalija Stepurko, is using proprietary technology to replace petroleum-based products 🧠 Cambridge Vision Technology, led by Andrew Kadis is developing technology for early detection of Alzheimer’s 🔋 Molyon, led by Ismail Sami, is building next-generation lithium batteries 💻 Nanomation, led by Teja Potocnik, is building computer vision software for the semiconductor industry 🎈 Orbit, led by Akshat Sharma, is building using non-invasive neuro-technology to transform mental health treatment ♻️ Protonera, led by Jack Chengzhi Guo, is digesting waste plastics with sunlight ⚡ VOLTQUANT, led by Nikita Dabizha, is fixing the UK electricity grid to enable Net Zero 🩺 William Oak Diagnostics, led by Alexander Patto, is developing effective testing for micronutrient deficiencies 🧫 xterna, led by Jessica Corry, is engineering novel solutions for cell-type specific drug delivery For more: - check out our company lookbook: https://bit.ly/4cc3ybB - read our writeup in forbes: https://bit.ly/43izBmf We wouldn't be here without our sponsors:  AstraZeneca, KPMG, and Hitachi, our partners Babraham Research Campus and Cambridge Judge Business School and our investment partner Parkwalk Advisors. Thank you all. Anne Dobrée, Gerard Grech, Alëna Protasova, Anca Belu, Smriti Sanchita.

#LeanLab2024: 𝗠𝗘𝗘𝗧 𝗧𝗛𝗘 𝗦𝗣𝗘𝗔𝗞𝗘𝗥𝗦! Vittorio Rossi - 𝘚𝘦𝘯𝘪𝘰𝘳 𝘊𝘰𝘯𝘴𝘶𝘭𝘵𝘢𝘯𝘵 LifeBee - will share insights from the last edition's 𝗟𝗲𝗮𝗻 𝗟𝗮𝗯 𝗦𝘂𝗿𝘃𝗲𝘆: an in-depth analysis of the current state of #LifeScience labs, highlighting trends, experiences and key takeaways. There's still time to participate in the survey and contribute to this comprehensive snapshot of the landscape in life science laboratories: your input will help shape the future of lab practices and innovations! ▶ 𝗝𝗼𝗶𝗻 𝘁𝗵𝗲 𝗦𝘂𝗿𝘃𝗲𝘆: https://lnkd.in/d7XfMTYs? 🔍 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 #LeanLab 𝗳𝘂𝗹𝗹 𝗮𝗴𝗲𝗻𝗱𝗮: https://lnkd.in/dEC5Nk6a 📅 𝗝𝗼𝗶𝗻 𝘂𝘀 𝗼𝗻 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟭𝟵, 𝟮𝟬𝟮𝟰, 𝗶𝗻 𝗠𝗶𝗹𝗮𝗻 📝 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://lnkd.in/dZ-5HVfF